Orbimed Advisors - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 103 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$10,965,000
+101.6%
521,891
+86.7%
0.20%
+106.1%
Q2 2022$5,439,000
+814.1%
279,500
+935.2%
0.10%
+890.0%
Q1 2022$595,000
-66.0%
27,000
-62.1%
0.01%
-60.0%
Q4 2019$1,748,00071,3000.02%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,566,912$62,278,0004.80%
RiverVest Venture Management LLC 1,921,118$33,543,0003.68%
Burrage Capital Management LLC 161,628$2,822,0002.15%
AIGH Capital Management LLC 274,583$4,794,0001.95%
NEA Management Company, LLC 4,187,801$73,119,0001.93%
Novo Holdings A/S 2,445,147$42,692,0001.83%
Sio Capital Management, LLC 494,743$8,638,0001.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$60,218,0001.19%
Rock Springs Capital Management LP 1,496,525$26,129,0000.55%
Prosight Management, LP 60,250$1,052,0000.49%
View complete list of MIRUM PHARMACEUTICALS INC shareholders